Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population
| Title: | Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population |
|---|---|
| Authors: | Derek Lytle, Ana Gabriela Grajales Beltrán, Johnna Perdrizet, Nassim Ait Yahia, Alejandro Cane, Benjamin Yarnoff, Ruth Chapman |
| Source: | Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023) |
| Publisher Information: | Taylor & Francis Group, 2023. |
| Publication Year: | 2023 |
| Collection: | LCC:Immunologic diseases. Allergy LCC:Therapeutics. Pharmacology |
| Subject Terms: | pneumococcal disease, pcv20, cost-effectiveness analysis, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950 |
| More Details: | This study assessed the cost-effectiveness of the 20-valent pneumococcal conjugate vaccine (PCV20) in Canadian infants aged |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2164-5515 2164-554X 21645515 |
| Relation: | https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X |
| DOI: | 10.1080/21645515.2023.2257426 |
| Access URL: | https://doaj.org/article/0feaf406272f41d088edaf6ce870bc53 |
| Accession Number: | edsdoj.0feaf406272f41d088edaf6ce870bc53 |
| Database: | Directory of Open Access Journals |
| ISSN: | 21645515 2164554X |
|---|---|
| DOI: | 10.1080/21645515.2023.2257426 |
| Published in: | Human Vaccines & Immunotherapeutics |
| Language: | English |